Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System
1. SNN launches CENTRIO Platelet-Rich-Plasma System for chronic wound management. 2. Product received CMS coverage for diabetic wounds since April 2021. 3. System facilitates point-of-care customization for various wound types. 4. Clinical trials support CENTRIO's effectiveness in wound healing. 5. Exclusive distribution agreement with Nuo Therapeutics boosts U.S. market entry.